Virax Biolabs Group Limited (VRAX) Stock Price, Quote & News

Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 7788 7414

Website: viraxbiolabs.com

Address:

BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom

HouseOfTheDragons Oct. 3 at 2:41 AM

Looks like volume & momentum could be shifting in to ASTC! Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $BURU $CDIO $RDHL $SPRB $VRAX 22

0 · Reply

ucla44life Sep. 29 at 6:28 PM

$VRAX LOWER, LOWER, LOWER ON THIS SCAM...DON'T GET CAUGHT HOLDING THE BAG LIKE ALL THE OTHER LOSERS OVER THE PAST YEAR....CHART STRAIGHT DOWN FROM $4+ FOR A REASON DURRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRR

0 · Reply

ucla44life Sep. 29 at 5:56 PM

$VRAX STINKY PINKY ALERT - SCAM, SCAM, SCAM!

0 · Reply

ucla44life Sep. 29 at 3:22 PM

$VRAX these bag holders about to get ruined with the next step lower, then lower, then lower....THE SCAM THAT KEEPS ON SCAMMING...not one can even give a reason why they're bullish....you know why? BECAUSE THERE IS NONE!!! ABSOLUTE TRASH RUN BY A CON-ARTIST

0 · Reply

RAFN Sep. 27 at 12:04 AM

$PSTV $ENVB $SONM $VRAX 0.60

0 · Reply

ucla44life Sep. 26 at 5:30 PM

$VRAX Poo-Poo

0 · Reply

BUYdontCRY Sep. 26 at 12:35 PM

$VRAX saw some loading this one last few weeks. .90 cash per share and only a 4M float with 10% short. Meeting with FDA “early September” well it’s almost over now…. Give me $1.20

1 · Reply

ucla44life Sep. 25 at 3:39 PM

$VRAX Next leg down incoming and all the new bag holders going to wonder why....THIS IS A SCAM durrrrrrrrrrrrrrrrrrrrr This never-ending cycle of crushing people just won't stop...from $4+ straight down to pennies....going to be epic when the inevitable trips comes or reverse split and all these losers are left with nothing. Couple months more before Nasdaq pulls the plug as compliance isn't met weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee WHAT AN ABSOLUTE SCAM RUN BY A CON-ARTIST!!! crazy how people don't listen or see the FACTS!!! oh well, YOU LOSE WHOMP, WHOMP!!!

0 · Reply

Trajdiiiiiiiie Sep. 23 at 3:38 PM

$VRAX added

1 · Reply

martins1 Sep. 23 at 12:19 PM

$VRAX $GOVX new viruses everywhere… 😂🚀

1 · Reply

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Jul 29, 2025, 7:35 AM EDT - 2 months ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Jul 18, 2025, 4:15 PM EDT - 2 months ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Mar 31, 2025, 2:57 PM EDT - 6 months ago

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Mar 18, 2025, 7:30 AM EDT - 7 months ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 13, 2025, 7:30 AM EDT - 7 months ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 7 months ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Feb 25, 2025, 7:00 AM EST - 7 months ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Jan 23, 2025, 3:35 PM EST - 9 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Jan 13, 2025, 9:20 AM EST - 9 months ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Dec 17, 2024, 7:30 AM EST - 10 months ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 10, 2024, 7:30 AM EST - 10 months ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Aug 29, 2024, 9:03 AM EDT - 1 year ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 28, 2024, 2:18 PM EDT - 1 year ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 23, 2024, 4:09 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 10:20 AM EDT - 1 year ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs to Participate at ESCMID Global 2024

Dec 21, 2023, 7:30 AM EST - 1 year ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 14, 2023, 7:30 AM EST - 1 year ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Sep 12, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 1, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Jul 18, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

May 4, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Apr 19, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Mar 10, 2023, 5:17 PM EST - 2 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 2 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 7, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Feb 7, 2023, 9:15 AM EST - 2 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Feb 7, 2023, 8:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Feb 6, 2023, 4:05 PM EST - 2 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Jan 4, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Dec 6, 2022, 7:30 AM EST - 3 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Nov 15, 2022, 7:30 AM EST - 3 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 8, 2022, 4:30 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Oct 26, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Sep 22, 2022, 8:07 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

COSM

Sep 12, 2022, 7:00 AM EDT - 3 years ago

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Sep 6, 2022, 4:00 PM EDT - 3 years ago

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Aug 16, 2022, 7:31 AM EDT - 3 years ago

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Jul 26, 2022, 8:00 AM EDT - 3 years ago

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

HouseOfTheDragons Oct. 3 at 2:41 AM

0 · Reply

ucla44life Sep. 29 at 6:28 PM

0 · Reply

ucla44life Sep. 29 at 5:56 PM

$VRAX STINKY PINKY ALERT - SCAM, SCAM, SCAM!

0 · Reply

ucla44life Sep. 29 at 3:22 PM

0 · Reply

RAFN Sep. 27 at 12:04 AM

$PSTV $ENVB $SONM $VRAX 0.60

0 · Reply

ucla44life Sep. 26 at 5:30 PM

$VRAX Poo-Poo

0 · Reply

BUYdontCRY Sep. 26 at 12:35 PM

$VRAX saw some loading this one last few weeks. .90 cash per share and only a 4M float with 10% short. Meeting with FDA “early September” well it’s almost over now…. Give me $1.20

1 · Reply

ucla44life Sep. 25 at 3:39 PM

0 · Reply

Trajdiiiiiiiie Sep. 23 at 3:38 PM

$VRAX added

1 · Reply

martins1 Sep. 23 at 12:19 PM

$VRAX $GOVX new viruses everywhere… 😂🚀

1 · Reply

TrdrBuckNKy Sep. 23 at 11:47 AM

$VRAX 46,000 shares bought up @ 7:15 EST...

1 · Reply

martins1 Sep. 23 at 11:38 AM

$VRAX huge bid now

0 · Reply

martins1 Sep. 23 at 11:19 AM

$VRAX pre sub Fda September… News ? Let’s break .70

0 · Reply

martins1 Sep. 23 at 11:18 AM

$VRAX moving

0 · Reply

Chief1912 Sep. 22 at 5:06 PM

$VRAX come on mr ceo… say something for your salary before it runs out

0 · Reply

davilastocks Sep. 22 at 4:45 PM

🚨 3 Penny Stocks Under $1 to Watch (Sep ’25) 🚨 Hemostemix $HEM: Stem-cell therapy microcap 💉 GEE Group $JOB: Staffing pivot to AI recruiting 🤖 Virax Biolabs $VRAX: Immune diagnostics & T-cell profiling 🧬 microcaps with biotech & AI catalysts.

0 · Reply

ucla44life Sep. 22 at 3:56 PM

$VRAX WHOMP, WHOMP!!! The new batch of bag holders gonna hate their investment, just like all the others weeeeeeeeeeeeeeeeeee

0 · Reply

ucla44life Sep. 19 at 8:51 PM

$VRAX More new bag holders being created on this SCAM...so sad they keep losing and losing

1 · Reply

Grystone Sep. 19 at 3:18 PM

$VRAX this is going to $10 dollars

3 · Reply

Young_Korean Sep. 19 at 1:42 PM

$VRAX RS! Sorry

1 · Reply

Peric2 Sep. 18 at 6:26 PM

$VRAX Anyone's know something about meeting,like beginning of the month past long ago,🤤😉😅😂

0 · Reply

Jspence0427 Sep. 18 at 2:17 PM

$VRAX soooo?

0 · Reply

Market Cap	2.68M
Revenue (ttm)	10,000.00
Net Income (ttm)	-6.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-60,600.00%
Debt to Equity Ratio	0.01

Volume	146,900
Avg Vol	715,274
Day's Range	N/A - N/A
Shares Out	4.34M
Stochastic %K	36%
Beta	1.64
Analysts	Sell
Price Target	$3.00